Recent Finacing
Recent Raise
NeuroQuest develops blood-based immune biomarkers for Alzheimer’s and ALS diagnostics and is preparing clinical studies with the Harvard Clinical Research Institute while establishing a U.S. clinical/regulatory center in Charleston.
Focus Areas
Recent Investors
Funding round
Investor